recent publications

• academic article

  • Berger, P. B., Best, P. J. M., Topol, E. J., White, J., DiBattiste, P. M., Chan, A. W., Kristensen, S. D., Herrmann, H. C., Moliterno, D. J. The relation of renal function to ischemic and bleeding outcomes with 2 different glycoprotein iib/iiia inhibitors: The do tirofiban and reopro give similar efficacy outcome (target) trial American Heart Journal  2005 149:869-875  DOI:10.1016/j.ahj.2004.12.002  PMID:15894970
  • Chan, A. W., Yadav, J. S., Bhatt, D. L., Bajzer, C. T., Gum, P. A., Roffi, M., Cho, L., Agah, R., Topol, E. J. Comparison of the safety and efficacy of emboli prevention devices versus platelet glycoprotein IIb/IIIa inhibition during carotid stenting American Journal of Cardiology  2005 95:791-795  DOI:10.1016/j.amjcard.2004.11.041  PMID:15757616
  • Vivekananthan, D. P., Bhatt, D. L., Chew, D. P., Zidar, F. J., Chan, A. W., Moliterno, D. J., Ellis, S. G., Topol, E. J. Effect of clopidogrel pretreatment on periprocedural rise in c-reactive protein after percutaneous coronary intervention American Journal of Cardiology  2004 94:358-360  DOI:10.1016/j.amjcard.2004.04.035  PMID:15276105
  • Chan, A. W., Moliterno, D. J., Berger, P. B., Stone, G. W., DiBattiste, P. M., Yakubov, S. L., Sapp, S. K., Wolski, K., Bhatt, D. L., Topol, E. J. Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival - results from the do tirofiban and reopro give similar efficacy outcome trial (target) Journal of the American College of Cardiology  2003 42:1188-1195  DOI:10.1016/s0735-1097(03)00944-6  PMID:14522478
  • Chan, A. W., Bhatt, D. L., Chew, D. P., Reginelli, J., Schneider, J. P., Topol, E. J., Ellis, S. G. Relation of inflammation and benefit of statins after percutaneous coronary interventions Circulation  2003 107:1750-1756  DOI:10.1161/01.cir.0000060541.18923.e9  PMID:12665489
  • Chan, A. W., Quinn, M. J., Bhatt, D. L., Chew, D. P., Moliterno, D. J., Topol, E. J., Ellis, S. G. Mortality benefit of beta-blockade after successful elective percutaneous coronary intervention Journal of the American College of Cardiology  2002 40:669-675  DOI:10.1016/s0735-1097(02)02013-2  PMID:12204496
  • Chan, A. W., Bhatt, D. L., Chew, D. P., Quinn, M. J., Moliterno, D. J., Topol, E. J., Ellis, S. G. Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention Circulation  2002 105:691-696  DOI:10.1161/hc0602.103586  PMID:11839623
  • Chan, A. W., Chew, D. P., Bhatt, D. L., Moliterno, D. J., Topol, E. J., Ellis, S. G. Long-term mortality benefit with the combination of stents and abciximab for cardiogenic shock complicating acute myocardial infarction American Journal of Cardiology  2002 89:132-136  DOI:10.1016/s0002-9149(01)02188-9  PMID:11792330